Table 4.
Entry No. | Peptide Sequencea | SHP-1 | SHP-2 | ||||
---|---|---|---|---|---|---|---|
kcat (s−1) | KM (μM) | kcat/KM (μM−1 s−1) | kcat (s−1) | KM (μM) | kcat/KM (μM−1 s−1) | ||
1 | WAGDDpYAA | 57 ± 2 | 45 ± 5 | 1.3 | 36 ± 3 | 68 ± 15 | 0.53 |
2 | FDIDIpYAA | 33 ± 1 | 13 ± 1 | 2.5 | 30 ± 2 | 39 ± 5 | 0.77 |
3 | EIFDFpYAA | 32 ± 2 | 27 ± 4 | 1.2 | 26 ± 1 | 54 ± 6 | 0.48 |
4 | FYDIDpYAA | 66 ± 2 | 28 ± 2 | 2.4 | 50 ± 4 | 66 ± 13 | 0.75 |
5 | SASASpYSASA | 26 ± 4 | 1990 ± 420 | 0.013 | 42 ± 5 | 2300 ± 400 | 0.018 |
6 | WDEDFpYSASA | 37 ± 2 | 53 ± 10 | 0.70 | 50 ± 3 | 46 ± 10 | 1.1 |
7 | SASASpYDWEF | 12 ± 1 | 48 ± 9 | 0.25 | 35 ± 1 | 180 ± 7 | 0.19 |
8 | WDEDFpYDWEF | 75 ± 2 | 3.2 ± 0.3 | 23 | 43 ± 1 | 6.3 ± 0.4 | 6.8 |
9 | WRKRFpYDWEF | 1.7 ± 1.0 | 780 ± 640 | 0.0022 | 1.3 ± 0.2 | 560 ± 140 | 0.0023 |
10 | WDEDFpYRWKF | 42 ± 2 | 150 ± 15 | 0.28 | 73 ± 7 | 210 ± 35 | 0.34 |
11 | WDEDFpYAA | 48 ± 2 | 43 ± 2 | 1.1 | |||
12 | FDEDFpYAA | 30 ± 2 | 31 ± 6 | 1.0 | |||
13 | ADEDFpYAA | 28 ± 1 | 34 ± 2 | 0.82 | |||
14 | DWEDFpYAA | 30 ± 1 | 17 ± 2 | 1.7 | |||
15 | DFEDFpYAA | 37 ± 1 | 23 ± 2 | 1.6 | |||
16 | DAEDFpYAA | 30 ± 1 | 28 ± 3 | 1.1 | |||
17 | AKFEDTpYAA | 19 ± 2 | 58 ± 13 | 0.34 | |||
18 | AVWEFpYpYAA | 24 ± 2 | 7.5 ± 2 | 3.3 | |||
19 | AYTEpYTpYAA | 17 ± 1 | 9.1 ± 1 | 1.9 | |||
20 | AWSpYADpYAA | 13 ± 1 | 22 ± 5 | 0.58 |
All peptides contain an N-terminal acetyl group and a C-terminal amide. Data reported represented the mean ± SD from three or more independent sets of experiments.